Table 2.

Significant differentially expressed miRNA profile in UA patients treated with or without statin

Whole blood	Score(d)	Fold change	q-value(%)	Plasma	Score(d)	Fold change	q-value(%)
hsa-miR-191	3.9826	2.0182	<0.0001%	hsa-miR-21	4.0676	9.6700	<0.0001%
hsa-miR-92a	3.8634	2.6235	<0.0001%	hsa-miR-223	3.4159	8.6072	<0.0001%
hsa-miR-532-3p	3.3904	2.4110	<0.0001%	hsa-miR-106a	3.1782	5.9014	<0.0001%
hsa-miR-574-3p	3.1517	2.7277	<0.0001%	hsa-miR-17	3.0701	5.7191	<0.0001%
hsa-miR-30b	3.0671	2.2520	<0.0001%	hsa-miR-320	2.7697	7.9742	<0.0001%
hsa-miR-486-5p	3.0474	2.2180	<0.0001%	hsa-miR-24	2.5543	5.1630	<0.0001%
hsa-miR-223	3.0328	2.3800	<0.0001%	hsa-miR-146b-5p	2.4747	16.9902	<0.0001%
hsa-miR-30c	2.9640	2.1134	<0.0001%	hsa-miR-142-3p	2.4040	16.8645	<0.0001%
hsa-miR-484	2.9314	2.4529	<0.0001%	hsa-miR-19b	2.3810	7.1494	<0.0001%
hsa-miR-451	2.8041	3.1920	<0.0001%	hsa-miR-19a	2.2580	9.1338	<0.0001%
hsa-miR-331-3p	2.6506	1.8440	<0.0001%	hsa-miR-30a-5	2.1183	9.2122	<0.0001%
hsa-miR-25	2.6181	2.3039	<0.0001%	hsa-miR-222	2.0399	8.4189	<0.0001%
hsa-miR-222	2.5022	2.0910	<0.0001%	hsa-miR-126	2.0359	7.1429	<0.0001%
hsa-miR-652	2.4739	2.4337	<0.0001%	hsa-miR-451	1.9745	9.8249	<0.0001%
hsa-miR-19b	2.4250	2.0244	<0.0001%	hsa-miR-197	1.9738	2.7519	<0.0001%
hsa-miR-15b	2.2769	2.2809	<0.0001%	hsa-miR-92a	1.9470	6.4763	<0.0001%
hsa-miR-140-3p	2.2018	1.9416	<0.0001%	hsa-miR-20a	1.9312	6.8796	<0.0001%
hsa-miR-26a	2.1192	2.3774	<0.0001%	hsa-miR-29a	1.8389	4.4884	<0.0001%
hsa-miR-324-3p	2.1131	1.8923	<0.0001%	hsa-miR-146a	1.7932	7.7389	<0.0001%
hsa-miR-150	2.0946	1.7147	<0.0001%
hsa-miR-93	2.0697	2.4706	<0.0001%
hsa-miR-106a	2.0101	2.2727	<0.0001%

22 whole blood miRNAs and 19 plasma miRNAs were significantly different between the statin treatment group and the control group.